#VisualAbstract: Hepatitis E vaccine shows promising 10-year efficacy in the Chinese population
1. Overall vaccine efficacy ranged from 83.1% to 86.6% during the 10-year period. 2. Detectable concentrations of antibodies persisted at ...
Tag: liver
Hepatitis E vaccine shows promising 10-year efficacy in the Chinese population
1. Overall vaccine efficacy ranged from 83.1% to 86.6% during the 10-year period. 2. Detectable concentrations of antibodies persisted at ...
#VisualAbstract: Resmetirom improves outcomes in patients with nonalcoholic steatohepatitis (NASH) compared to placebo
Click here to read this study in NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without ...
Camrelizumab plus rivoceranib superior to sorafenib for treatment of unresectable hepatocellular carcinoma
1. Patients in the camrelizumab-rivoceranib group reported significantly greater progression-free survival than the sorafenib group. 2. Treatment-related deaths were comparable ...
Combination of buprenorphine and naloxone may be safe for those hospitalized with acute hepatitis A
1. This quantitative study found that buprenorphine/naloxone can be safely administered to patients with acute hepatitis A without increased risk ...
Terlipressin improved renal function in patients with type 1 hepatorenal syndrome
1. Administration of intravenous terlipressin was shown to improve kidney function in hospitalized patients with type 1 hepatorenal syndrome. 2. ...
Increased albumin infusions did not improve decompensated cirrhosis
1. Administration of human albumin solution was shown not to lead to any clinical improvement in patients hospitalized with cirrhosis. ...
#VisualAbstract: Adjunctive methylprednisolone treatment for hepatitis B acute-on-chronic liver failure associated with increased survival
1. Adding methylprednisolone to standard treatment in hepatitis B virus-related acute-on-chronic liver failure was associated with an increase in 6-month ...
#VisualAbstract: Sarcopenia associated with reduced muscle mass and strength following liver resection for malignant neoplasms
1. Sarcopenia was an independent risk factor for reduced muscle mass and strength following liver resection for malignant neoplasms. Evidence ...
Transfusion worsens outcomes for HCV+ liver transplant recipients
Image: PD 1) Hepatitis C virus (HCV) liver transplant (LT) recipients receiving perioperative transfusions have increased fibrosis and decreased 1- ...
License Our Award-Winning Physician-Written Medical News and Visual Abstracts
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
